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The current severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2) pandemic 
forces medical personnel to search for alternative 
early diagnosis methods of the patient’s condi-
tion [1]. An essential element of the diagnosis 
of a patient with COVID-19 is to understand the 
impact of various laboratory tests on the sever-
ity of the disease. An example of this research 
can be determining the level of ferritin, which is 
considered an indicator of the body’s iron supply. 
As iron levels fall, the blood ferritin levels fall [2]. 
The concentration of 1 µg/L corresponds to 8 mg 
of iron in the reserve pool [3]. When healthy, 20% 
of the body’s iron is bound to ferritin. Ferritin 
bound iron accounts for 95% of the hepatic iron 
stores. According to World Health Organization, 
adult women’s norm ranges from 15 to 150 µg/L, 
for men from 15 to 200 µg/L [4]. Moreover, fer-
ritin is considered an acute phase protein, so its 
concentration also increases inflammation and 
infections. This limits the possibility of using its 
determination to assess systemic iron resources, 
even in terms of the diagnosis of COVID-19 sever-
ity [5, 6]. Abbaspour et al. [7] showed that ferritin 
is a crucial mediator of immune dysregulation via 
direct immune-suppressive and pro-inflammatory 
effects, contributing to cytokine storm.
The present study aimed to determine the 
usefulness of ferritin as a predictor of a patient’s 
severity with COVID-19 in a performer systematic 
review and meta-analysis. This study followed the 
Preferred Reporting Items for Systematic Reviews 
and Meta-Analysis (PRISMA) guidelines [8] and the 
Meta-analysis Of Observational Studies in Epidemiol-
ogy (MOOSE) guidelines for reporting systematic re-
views and meta-analyses of observational studies [9].
Three authors (L.S., J.S., and S.B) indepen-
dently searched relevant literature. The current 
Pubmed, Embase, Cochrane, Web of Science, Scop-
us (from database inception to November 10, 2020) 
was explored. The whole search strategy used 
free words, including “ferritin” AND “COVID-19” 
covid-19
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Figure 1. Forest plot of ferritin levels in severe versus non-severe groups. The center of each square represents the 
odds ratio for individual trials, and the corresponding horizontal line stands for a 95% confidence interval (CI). The 
diamonds represent pooled results; SD — standard deviation.
OR “SARS-CoV-2”. The reference lists of all 
eligible trials and reviews were screened for ad-
ditional citations. Publications were restricted to 
the English language.
Twenty studies reported ferritin levels in 
severe and non-severe patient groups. Polled 
analysis showed that it significantly correlated 
higher ferritin levels with the more severe condi-
tion of the COVID-19 patient (MD: 406.98; 95% 
CI: 319.41–494.55; p < 0.001; I2: 94%; Fig. 1). De-
tailed characteristics of the studies included in the 
meta-analysis are presented in Supplementary 
Digital Content. Higher ferritin levels were also 
associated with more frequent hospitalization in 
intensive care unit conditions (MD: 748.96; 95% 
CI: 444.45–1053.48; p < 0.001; I2: 89%), and higher 
mortality in COVID-19 patients (MD: 594.43; 95% 
CI: 345.7–843.17; p < 0.001; I2: 99%; Supplemen-
tary Digital Content).
In conclusion, this systematic review and 
meta-analysis show a close correlation between 
ferritin levels and the state of the COVID-19 pa-
tient. Higher ferritin levels were associated with 
a more severe patient condition, more intensive 
care unit exposure, and higher mortality.
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